Demographic characteristics and comorbidities in patients with and without FM
Variable | FM | P value | |
No | Yes | ||
n=132 863 | n=33 216 | ||
Sex | n (%) | n (%) | 0.99 |
Female | 71 880 (54.1) | 17 970 (54.1) | |
Male | 60 983 (45.9) | 15 246 (45.9) | |
Age, mean (SD) | 50.9 (16.9) | 51.4 (16.7) | <0.001* |
Stratify age | 0.99 | ||
≤49 | 64 292 (48.4) | 10 673 (48.4) | |
50–65 | 36 820 (27.7) | 9205 (27.7) | |
65+ | 31 751 (23.9) | 7938 (23.9) | |
Comorbidity | |||
Diabetes | 10 485 (7.89) | 3193 (9.61) | <0.001 |
Hypertension | 37 284 (28.1) | 11 287 (34.0) | <0.001 |
Hyperlipidaemia | 22 446 (16.9) | 7301 (22.0) | <0.001 |
Depression | 4690 (3.53) | 1804 (5.43) | <0.001 |
Anxiety | 10 494 (7.90) | 4214 (12.7) | <0.001 |
Sleep disorder | 21 095 (15.9) | 8121 (24.5) | <0.001 |
CAD | 17 918 (13.5) | 5821 (17.5) | <0.001 |
CFS | 199 (0.15) | 93 (0.28) | <0.001 |
IBS | 5125 (3.86) | 1870 (5.63) | <0.001 |
Χ2 test; *two-sample t-test.
CAD, coronary artery disease; CFS, chronic fatigue syndrome; FM, fibromyalgia; IBS, irritable bowel syndrome.